The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dose-dense R-CHOP (administered every 2 weeks) with sargramostim in patients with newly diagnosed diffuse large B-cell lymphoma.
Preeti Chaudhary
No relevant relationships to disclose
Susan G. Groshen
No relevant relationships to disclose
Denice D Tsao-Wei
No relevant relationships to disclose
Imran Siddiqi
No relevant relationships to disclose
Vinay Duddalwar
No relevant relationships to disclose
Nancy Berman
No relevant relationships to disclose
Christine Duran
No relevant relationships to disclose
Teh-Chun Wang
No relevant relationships to disclose
Anil Tulpule
No relevant relationships to disclose